ERAS · Erasca, Inc.
$18.38
+0.52 (+2.91%)
At close · Aug 14
Market Cap
$6.43B
Shares
349.76M
Erasca, Inc. Earnings Call Transcripts
Every quarterly earnings call for Erasca, Inc. (ERAS) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Earnings call
FY24 · Q1
2024-05-08
Erasca, Inc. Q1 FY2024 Earnings Call
Diluted EPS
$-0.23
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-27
Erasca, Inc. Q4 FY2023 Earnings Call
Confident tone
Naporafenib (Napo) clinical program
Phase 3 trial design and dose optimization
Pan-KRAS inhibitor program
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–2 of 2 earnings calls
Key facts
CIK
1761918
CUSIP
29479A108
13F (30d)
248 filings
247 filers
Visit website
Investor relations